. Equinatoxin II (EqtII), a lysin from the sea anemone Actinia equina L., is one of the Borut Š trukelj 2 , Franc Gubenšek 2 and Peter Maček more extensively studied cytolysins (Maček and Lebez, 1988 Maček et al., 1994) . A cationselective channel with a hydrodynamic inner diameter of 1-The role of the N-terminal segment 1-33 of equinatoxin II, 2 nm is composed of three or four monomers as deduced from a 20 kDa pore-forming protein from the sea anemone kinetic measurements and cross-linking experiments (Belmonte Actinia equina, was studied by N-truncation mutagenesis . et al., 1993).
Introduction
Boehringer-Mannheim or New England Biolabs. All other Pore-forming toxins (Harvey, 1990) are water-soluble polypepchemicals of analytical grade were obtained from Sigma or tides which insert into cell or model lipid membranes and Serva, unless stated otherwise. Oligonucleotides were purpermeabilize them. They have been found, for example, in chased from Ransom Hill Bioscience or synthesized on an bacteria , sea anemones (Maček, 1992) Applied Biosystems 381A DNA synthesizer and then purified and insect venoms (Dempsey, 1990) . The tertiary structure by a double precipitation with sodium acetate and ethanol. and precise mechanism of pore assembling have been deterThe bacterial strains Escherichia coli DH5α and E.coli mined for only a few of them (Dempsey, 1990; Parker et al., BLR(DE3) were obtained from Gibco BRL and Novagen, 1994; Stroud, 1995) respectively. From sea anemones, more than 30 pore-forming cytolysins
Cloning of EqtII mutants have been isolated. They are highly basic proteins with a molecular mass of~20 kDa (Kem, 1988; Turk, 1991; Maček, The wild-type EqtII coding region was cloned as described previously (Anderluh et al., 1996) . The coding regions for N-1992). So far, the primary structure has been completed for only three of them (Blumenthal and Kem, 1983; Simpson terminal truncated mutants were amplified by PCR using the EqtII cDNA. The 3Ј-primer was in all cases E2.2(-) (5Ј-et al., 1990; Belmonte et al., 1994) . Analysis of the complete and partial N-terminal amino acid sequences of several similar CGAATTCGGATCCTATCAAGCTTTGCTCACGT-3Ј). It is complementary to the last 14 nucleotides of the EqtII cDNA sea anemone cytolysins revealed no similarity with other proteins and they probably represent a novel protein superfamcoding region and contains two termination codons and EcoRI and BamHI sites. The 3Ј-primer was used in combination with ily. Typical of the sea anemone cytolysins is their inhibition by sphingomyelin. Experiments with model lipid membranes the 5Ј-primers: ED1(ϩ) (5Ј-GGAATTCATATGGGGGC-CGTTATTGATGGTG-3Ј) for construction of EqtII∆1-5, showed that sphingomyelin in the membrane acts as a lipid acceptor (Linder et al., 1977; Belmonte et al., 1993; Maček ED2(ϩ) (5Ј-GGAATTCATATGGGTGCAAGTCTGTCC-3Ј) for EqtII∆1-10 and ED3(ϩ) (5Ј-GGAATTCATATGGCcolumn (Applied Biosystems) equilibrated in 0.1% trifluoroacetic acid in water. Elution was performed with a 30 min TGTCGGTGTCGAC-3Ј) for EqtII∆1-33. They all contain EcoRI and NdeI sites followed by a sequence corresponding linear gradient to 80% (v/v) acetonitrile with 0.1% (v/v) trifluoroacetic acid at a flow rate of 1 ml/min and absorbance to the desired 5Ј ends of the particular EqtII mutant. The NdeI site includes the initiator codon and is followed by a codon was monitored at 215 nm. The N-terminal sequence was determined by Edman degradation using an Applied Biofor an amino acid with a short side chain (Gly or Ala) which ensures efficient co-translational removal of the N-terminal systems 470A protein sequencer. Hemolytic activity was measured turbidimetrically on bovine methionine in the bacterial cell (Hirel et al., 1989) . PCR was performed using a Perkin-Elmer Cetus kit for 30 cycles red blood cells at 25°C as described previously (Maček and Lebez, 1988) . Toxins were added to 2 ml of a red blood with the following conditions: denaturation, 94°C for 1 min; annealing, 48°C for 1 min; and extension, 72°C for 1 min. The cell suspension in 0.13 M NaCl, 20 mM Tris-HCl, pH 7.4 (erythrocyte buffer) with an apparent absorbance of 0.5 at PCR products were digested at the ends with EcoRI and cloned into pUC19, where the nucleotide sequence was verified 700 nm. The measured half time of hemolysis, t 50 , was the time in which an apparent absorbance reduced to 0.25. One using a T7 sequencing kit (Pharmacia) and [ 35 S]dATPαS (Amersham). The coding regions were excised from pUC19 hemolytic unit (1 HU) was defined as a quantity of the toxin which reduced an apparent absorbance of the erythrocyte with NdeI and EcoRI and cloned into the pT7-7 expression vector (Tabor, 1994) . The expression vectors named pAG4.1, suspension at 700 nm from 0.5 to 0.25 in 2 min. pAG4.2 and pAG4.3 allow the production of EqtII∆1-5, Inhibition with sphingomyelin EqtII∆1-10 and EqtII∆1-33, N-terminal deletion mutants of A stock 4 mg/ml sphingomyelin dispersion was prepared in EqtII, respectively. distilled water using sonication with a microtip three times for Expression and isolation of EqtII mutants 20 s. The suspension was always vortex mixed before used. A 1 HU amount of the toxin was preincubated with sphingoThe constructed vectors were used to transform the E.coli myelin at a chosen concentration in 10 µl of erythrocyte buffer BLR(DE3) strain and expression of EqtII mutants was induced for 2 min at room temperature and the hemolytic activity of as described (Anderluh et al., 1996) . The same amount of the mixture was then measured as described. bacterial cells was taken for the determination of the hemolytic activity of supernatants. Cells were spun down, then 50 µl of Binding to red blood cells STET buffer (8% sucrose, 0.1% Triton X-100, 50 mM EDTA A 6.2 µg amount of the toxin variants was added to 500 µl of and 50 mM Tris-HCl, pH 8.0) and 1 µl of 50 mg/ml lysozyme the red blood cell suspension in erythrocyte buffer, supplewere added to the bacteria and incubated at room temperature mented with 30 mM PEG 4000, with an apparent absorbance for 10 min. Bacterial cells were briefly sonicated with a of 1.0 at 700 nm at 4°C. The mixture was incubated on ice microtip at 70 W (Ultrasonics W185 sonicator cell disrupter) for 5 min and then briefly centrifuged at the same temperature. and centrifuged for 10 min. The same amount of supernatant, A 100 µl volume of the supernatant was then used to measure usually 10 µl, was then used to determine the half time of hemolytic activity on an erythrocyte suspension as described. hemolysis as described (Maček and Lebez, 1988 ) (see also For the control, toxins were added to 500 µl of the PEG buffer characterization of proteins). Native and recombinant wildand hemolysis was measured as before. By using equivalents type and mutant Eqts were isolated as described previously of hemolytic units for each particular toxin variant, the binding (Maček and Lebez, 1988; Anderluh et al., 1996) . of toxins was quantified. For SDS-PAGE and immunoblot Characterization of recombinant proteins analysis, toxins (0.7 µg in 5 µl) were added to 20 µl of red blood cell suspension containing PEG. After incubation for A molar extinction coefficient of 3.61ϫ10 4 M -1 cm -1 (Maček 2 min on ice, the erythrocytes were centrifuged briefly and the and Lebez, 1988) was used to determine the concentration of supernatant was removed. An electrophoresis loading buffer native EqtII. The concentration of recombinant proteins was containing SDS was then added separately to erythrocytes and determined spectrophotometrically by the method of Perkins supernatant and both samples were analyzed on a Phast system (1986) or by Bio-Rad Protein assay using known concentrations with subsequent immunoblotting. of native EqtII as a standard.
Proteins were analyzed using an SDS-PAGE Phast system from Pharmacia. For the native electrophoresis 8-25% gradient Results gels with reversed electrodes were used following the instrucCloning and expression of N-truncated mutants of EqtII tions of the manufacturer.
The PCR amplified products coded for N-deletion mutants Polyclonal antibodies against EqtII were raised in a rabbit lacking 5, 10 or 33 amino acids from the N-terminal end. In and serum was used for immunoblotting without further order to exclude errors during PCR amplification using Taq purification. Proteins were blotted for 2 h to a polyvinylidene polymerase, the fragments were cloned into pUC19 where difluoride membrane (Millipore). The membrane was blocked nucleotide sequences was checked. In all cases they matched in buffer B, i.e. 1 M NaCl, 20 mM EDTA and 0.2 M Trisperfectly the corresponding regions of the EqtII cDNA. In HCl, pH 7.4 (buffer A) containing 4% BSA for 2 h. Incubation Figure 1A immunoblot analysis of the expressed proteins in with 30 µl of antiserum in 5 ml of buffer B was followed bacterial lysate is shown. Recombinant Eqts are all of the by incubation with peroxidase conjugated goat anti-rabbit expected size. The immunoblot shows that the level of expresantibodies (Jackson Immunoresearch), 1:1000 in buffer B. The sion was approximately the same for all three mutants and wildmembrane was extensively washed with buffer A between the type EqtII, which was about 5% of the total bacterial proteins. two steps. After the last incubation, the membrane was washed Isolation and characterization of N-truncated mutants again and developed using 3-amino-9-ethylcarbazole as a substrate.
Certain amounts of Eqts were expressed in the inactive form of insoluble inclusion bodies and part in the form of soluble Analytical RP-HPLC (Milton Roy) was performed on a C 18 failed to obtain any hemolytically active protein using this procedure. The initiator methionine was cleaved off efficiently in the case of recombinant EqtII and EqtII∆1-5 (Table I) . hemolytically active proteins. The bacterial supernatant of EqtII∆1-10 still possessed~10% of the methionine form, but EqtII∆1-33 showed no hemolytic activity, whereas the activity it was not possible to separate the isoforms by RP-HPLC (data of the EqtII∆1-5 and EqtII∆1-10 supernatant was reduced to not shown). 44 and 4%, respectively, compared with wild-type EqtII
Biological activity of recombinant proteins (Figure 2 ). Homogeneous EqtII∆1-5 and EqtII∆1-10 were
The specific hemolytic activity of EqtII∆1-5 and EqtII∆1-10 isolated from the bacterial supernatant as shown in Figure 1B . mutants was reduced to 89 and 31%, respectively, compared Some of the properties of recombinant Eqts are presented in with native and wild-type EqtII (Table I) . Table I . While recombinant EqtII has the same biochemical Progressive removal of 5 and 10 amino acids results in properties as the native ( Figure 1C and Table I ), the mutants differ in size and overall net charge. As deduced from native increased inhibition by sphingomyelin. Preincubation of the but with the bacterial α-toxin from Staphylococcus aureus. The N-terminal truncation mutants were able to bind to the erythrocyte membrane and form oligomers but they were not able to lyse red blood cells. The authors proposed that truncated mutants do not lack specific functions at deleted domains but rather that the accumulation of different aggregates of α-toxin on the membranes was promoted. An entirely different situation pertains with streptolysin O, a thiol-activated bacterial cytolysin, where modified N-termini affect neither pore formation nor hemolytic activity (Weller et al., 1996) . For EqtII we suggest that, regardless the role of the N-terminus, other part(s) should participate in the fully active molecule, unlike some pore-forming peptides Runnels and Scarlata, 1995; Andrä et al., 1996; Kerr et al., 1996; Oren and impaired if a single residue of either tyrosine (Turk et al., 1989) cells. SDS-PAGE and immunoblot analysis of free or cell-bound toxins.
or tryptophan (Turk et al., 1992) is modified. Furthermore,
Toxins were extracted from cell membranes with SDS as described in tryptophan residue(s), which are not present in the N-terminal Materials and methods. Free EqtII∆1-10 (lane 1), bound EqtII∆1-10 (lane moiety, were shown to interact with lipids (Maček et al., 1995) .
2), free wild-type EqtII (lane 3) and bound wild-type EqtII (lane 4).
Our results are also in agreement with a proposed multi-step model of pore formation by EqtII, based on the kinetic toxins with 60 µg/ml sphingomyelin reduced the hemolytic changes in intrinsic tryptophan fluorescence and of vesicle action of wild-type EqtII by more than 50%, that of EqtII∆1-permeabilization (Maček et al., 1995) . The existing data sug-5 by 70%, while the activity of EqtII∆1-10 was lost completely gest a model of EqtII binding to lipid membrane and pore ( Figure 3A) . In similar experiments (data not shown), we formation could be as follows. Initial interaction with sphingovaried the sphingomyelin concentration at a constant 1 HU of myelin at the membrane surface, the nature of which is toxins. In this case, the concentration of sphingomyelin needed unknown at present, triggers a conformational change in the for 50% reduction of hemolytic activity was more than five toxin, including that of the amphiphilic N-terminus. This may times lower in the case of EqtII∆1-10 mutant than wildreveal a larger hydrophobic surface of the protein which type EqtII.
promotes an insertional step leading to toxin oligomerization. Binding experiments showed that 49, 57 and 70% of wildIn structure-function studies of non-bacterial pore-forming type EqtII, EqtII∆1-5 and EqtII∆1-10, respectively, were toxins, molecular biological approaches have rarely been bound to the cells. The increased binding of EqtII∆1-10 is reported, unlike other types of toxins. A short cardiotonic also supported by monitoring toxin binding with SDS-PAGE neurotoxin from the sea anemone Anthopleura xanthogramand immunoblotting as shown for wild-type and EqtII∆1-10 mica and mutant forms, for example, were expressed in E.coli in Figure 3B . It is obvious that the EqtII∆1-10 recombinant by using synthetic genes (Gallagher and Blumenthal, 1992) . binds to red blood cells more tightly than the others.
Our study has proved the use of a bacterial expression system suitable for producing N-truncated mutants of the sea anemone Discussion pore-forming protein, and further mutagenesis of EqtII combined with biochemical and biophysical studies is under way The N-terminal truncation of EqtII might affect toxin folding and solubility, lipid recognition, binding and/or pore formation.
to obtain more details on the protein-lipid interactions. As the truncation mutant EqtII∆1-5 migrated closer to the
